{Reference Type}: Journal Article
{Title}: The Therapeutic Landscape in Chronic Cough.
{Author}: Smith JA;
{Journal}: Lung
{Volume}: 202
{Issue}: 1
{Year}: 2024 02 21
{Factor}: 3.777
{DOI}: 10.1007/s00408-023-00666-y
{Abstract}: In recent years, there has been a substantial increase in the development of antitussive therapies and the first new therapy, gefapixant has been licenced in Europe. This review describes current unlicenced treatments for chronic cough and details treatments currently in development for refractory chronic cough and cough in idiopathic pulmonary fibrosis, as well as compounds previously explored.